ReviewCardiovascular drugs and therapy2022

The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus.

Bertram Pitt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.